Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6525426rdf:typepubmed:Citationlld:pubmed
pubmed-article:6525426lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:6525426lifeskim:mentionsumls-concept:C1458155lld:lifeskim
pubmed-article:6525426lifeskim:mentionsumls-concept:C0006668lld:lifeskim
pubmed-article:6525426pubmed:issue5lld:pubmed
pubmed-article:6525426pubmed:dateCreated1985-3-28lld:pubmed
pubmed-article:6525426pubmed:abstractTextIn order to evaluate the frequency of elevated circulating calcitonin in patients with bone metastasis plasma calcitonin level was measured in 32 patients with breast carcinoma with and without bone metastasis. Calcitonin was found in normal ranges in all patients without metastasis. In patients with bone metastasis, 4 had normal level, 2 were found with elevated calcitonin. Our results suggest that elevated calcitonin is related to the presence of bone metastasis but is not a constant finding in these patients.lld:pubmed
pubmed-article:6525426pubmed:languagefrelld:pubmed
pubmed-article:6525426pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6525426pubmed:citationSubsetIMlld:pubmed
pubmed-article:6525426pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6525426pubmed:statusMEDLINElld:pubmed
pubmed-article:6525426pubmed:issn0753-3322lld:pubmed
pubmed-article:6525426pubmed:authorpubmed-author:BesnardJ CJClld:pubmed
pubmed-article:6525426pubmed:authorpubmed-author:BaulieuJ LJLlld:pubmed
pubmed-article:6525426pubmed:authorpubmed-author:GuilloteauDDlld:pubmed
pubmed-article:6525426pubmed:issnTypePrintlld:pubmed
pubmed-article:6525426pubmed:volume38lld:pubmed
pubmed-article:6525426pubmed:ownerNLMlld:pubmed
pubmed-article:6525426pubmed:authorsCompleteYlld:pubmed
pubmed-article:6525426pubmed:pagination268-9lld:pubmed
pubmed-article:6525426pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6525426pubmed:meshHeadingpubmed-meshheading:6525426-...lld:pubmed
pubmed-article:6525426pubmed:meshHeadingpubmed-meshheading:6525426-...lld:pubmed
pubmed-article:6525426pubmed:meshHeadingpubmed-meshheading:6525426-...lld:pubmed
pubmed-article:6525426pubmed:meshHeadingpubmed-meshheading:6525426-...lld:pubmed
pubmed-article:6525426pubmed:meshHeadingpubmed-meshheading:6525426-...lld:pubmed
pubmed-article:6525426pubmed:meshHeadingpubmed-meshheading:6525426-...lld:pubmed
pubmed-article:6525426pubmed:meshHeadingpubmed-meshheading:6525426-...lld:pubmed
pubmed-article:6525426pubmed:meshHeadingpubmed-meshheading:6525426-...lld:pubmed
pubmed-article:6525426pubmed:meshHeadingpubmed-meshheading:6525426-...lld:pubmed
pubmed-article:6525426pubmed:meshHeadingpubmed-meshheading:6525426-...lld:pubmed
pubmed-article:6525426pubmed:year1984lld:pubmed
pubmed-article:6525426pubmed:articleTitle[Plasma calcitonin and breast tumors].lld:pubmed
pubmed-article:6525426pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6525426pubmed:publicationTypeEnglish Abstractlld:pubmed